RZLT

Rezolute, Inc. Common Stock (NV)
Data: 2026-05-08
$3.155
Price
3.72%
Change
$11.46
52W High
$1.07
52W Low

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Quick Stats
May 08, 2026

57.3

AI Score

HOLD

0.11

Volume Ratio

May 12, 2026

Next Earnings

13

+ve Days (30d)

16

-ve Days (30d)

RZLT Stock Summary

Last updated

RZLT is currently trading at $3.155, positioned below its 200-day moving average of $5.59, suggesting bearish momentum. The stock has a 52-week range of $1.07 to $11.4565.

Technical Analysis: The 50-day moving average stands at $3.13, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads , suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is , which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates RZLT at 57.3/100 with a HOLD recommendation.

RZLT Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

RZLT Price vs Max Options Open Interest
RZLT Max Change In Options Open Interest

RZLT Options - Sort by Max open Interest (near term)

8th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

RZLT Daily Out of Money Options - Sort by Max open Interest (near term)

8th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

RZLT Daily In the Money Options - Sort by Max open Interest (near term)

8th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

RZLT Most Active Options by Volume(near term)

8th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Rezolute, Inc. Common Stock (NV) is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

RZLT Moving Averages Analysis

Rezolute, Inc. Common Stock (NV) has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on May 08, 2026

RZLT (Rezolute, Inc. Common Stock (NV)) Simple Moving Averages

Moving Averages are last updated May 08, 2026

Days MA
10 3.2
20 3.3
30 3.28
50 3.13
100 2.99
200 5.59

RZLT Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 300.5 million
Earnings/Share ($) -0.93
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.7475
EPS Estimate Next Year ($) -0.6843
WallStreet Target Price ($) 5.125
Most Recent Quarter